240 related articles for article (PubMed ID: 4890848)
1. Antilymphocyte serum: present status.
Shanfield I; MacLean LD
Can Med Assoc J; 1969 May; 100(20):925-30. PubMed ID: 4890848
[No Abstract] [Full Text] [Related]
2. [Current status of immunosuppression].
Kaspar F
Dtsch Med J; 1968 Apr; 19(7):211-3. PubMed ID: 4180292
[No Abstract] [Full Text] [Related]
3. [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].
Lawson RK; Kirchheim D
Urologe; 1967; 6(6):359-67. PubMed ID: 4873352
[No Abstract] [Full Text] [Related]
4. Studies on the mechanism of rejection of tolerated skin homografts and abrogation of immunological tolerance by hyperimmune serum.
Hasek M; Skamene E; Karakoz I; Chutná J; Nouza K; Bubeník J; Sovová V; Nĕmec M; Jonák J
Folia Biol (Praha); 1968; 14(6):411-24. PubMed ID: 4236901
[No Abstract] [Full Text] [Related]
5. [Transplantation and immunology].
Brendel W
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1970; 196(1):39-56. PubMed ID: 4911589
[No Abstract] [Full Text] [Related]
6. Anti-lymphocyte serum.
James K
Clin Chim Acta; 1968 Sep; 22(1):101-13. PubMed ID: 4973561
[No Abstract] [Full Text] [Related]
7. Immunological aspects of organ and tissue transplantation.
Nelson DS
Med J Aust; 1968 Oct; 2(15):607-12. PubMed ID: 4176982
[No Abstract] [Full Text] [Related]
8. An introduction to immunosuppressants.
Aisenberg AC
Adv Pharmacol Chemother; 1970; 8():31-55. PubMed ID: 4400437
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive agents].
Pelletier G
Laval Med; 1970 Nov; 41(11):1156-60. PubMed ID: 4394730
[No Abstract] [Full Text] [Related]
10. Antilymphocyte serum: summary and further observations.
Woodruff MF
Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
[No Abstract] [Full Text] [Related]
11. The passenger cell concept in transplantation immunology.
Billingham RE
Cell Immunol; 1971 Feb; 2(1):1-12. PubMed ID: 4399153
[No Abstract] [Full Text] [Related]
12. [Experimental lung transplantation. Immunosuppressive therapy].
Morino F; Olivero S; Vezzosi E; Bezzi P; Ibba F; Gallingani R; Sanfelici G
Minerva Med; 1969 Mar; 60(21):903-17. PubMed ID: 4888328
[No Abstract] [Full Text] [Related]
13. Antilymphocyte serum or antithymus serum.
Nagaya H
Arch Intern Med; 1970 Mar; 125(3):499-502. PubMed ID: 4906901
[No Abstract] [Full Text] [Related]
14. Mode of action of antilymphocyte serum.
DeMeester TR
Surg Gynecol Obstet; 1969 Oct; 129(4):717-22. PubMed ID: 4898242
[No Abstract] [Full Text] [Related]
15. Immunological enhancement.
Russell PS
Transplant Proc; 1971 Mar; 3(1):960-6. PubMed ID: 4941150
[No Abstract] [Full Text] [Related]
16. [Appearance of circulating, precipiting antibodies, horse antiproteins in patients with renal grafts treated with antilymphocyte serum].
Druet P; Bariéty J; Lagrue G; Idatte JM
J Urol Nephrol (Paris); 1969 Dec; 75(12):999-1005. PubMed ID: 4907894
[No Abstract] [Full Text] [Related]
17. Graft rejection.
Feldman JD
Arch Intern Med; 1969 Jun; 123(6):713-8. PubMed ID: 4890441
[No Abstract] [Full Text] [Related]
18. A new in vitro test evaluating anti-lymphocyte serum potency.
Bach JF; Dardenne M; Dormont J; Antoine B
Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
[No Abstract] [Full Text] [Related]
19. Permanent survival of dog renal allografts after a limited course of antilymphocyte serum treatment.
Shanfield I; Wren SF; Blennerhassett JB
Surg Forum; 1969; 20():304-5. PubMed ID: 4910606
[No Abstract] [Full Text] [Related]
20. Lymphocytes and antilymphocytic serum.
Woodruff M
Endeavour; 1969 May; 28(104):65-7. PubMed ID: 4183771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
